Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH
In All, PortfolioStudy to be presented at 3rd Global NASH Congress in London, U.K., February 10, 11 Data show, for the first time, that INDY inhibition attenuates diet-induced NASH and mINDY inhibitors may be a novel therapeutic option In a murine NASH model, a small molecule INDY…